[Heart rate control: f-channel blockers].
Kryzhanovskiĭ
S A
SA
Vititnova
M B
MB
D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D054815:Cyclic Nucleotide-Gated Cation Channels / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D015640:Ion Channel Gating; D000077550:Ivabradine; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000503:physiopathology; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D001552:Benzazepines; D002121:Calcium Channel Blockers; D054815:Cyclic Nucleotide-Gated Cation Channels; D000077550:Ivabradine